Norgine is a European specialist pharmaceutical company with a direct commercial presence in all major European markets. They operate a well-established European infrastructure to develop, manufacture and commercialise products.

Braintree Laboratories manufactures pharmaceutical products. It offers SUPREP bowel preparation kit, an osmotic laxative for cleansing of the colon in preparation for colonoscopy in adults; NuLYTELY, a prescription medicine for adults and children for bowel cleansing prior to colonoscopy; and GoLYTELY, a lavage preparation solution for diabetic, hypertensive, cardiac, and renal patients, as well as patients with electrolyte imbalances. The company also provides Suclear, a sodium sulfate, potassium sulfate, and magnesium sulfate oral solution for cleansing of the colon as a preparation for colonoscopy in adults; and PEG-3350, a sodium chloride, sodium bicarbonate, and potassium chloride oral solution for cleansing of the colon as a preparation for colonoscopy in adults.

Ironwood Pharmaceuticals, Inc is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.. Microbia was founded by postdocs from the lab of Gerald Fink at the Whitehead Institute to commercialize approaches that had been developed in the lab to improve industrial fermentation of fungi, to genetically engineer them to produce secondary metabolites more efficiently or to produce new ones as leads for drug discovery or as products for use in industry, and to identify drug targets in fungi for antifungal drug discovery. In 2002 the company hired John Talley to lead their antifungal drug discovery efforts, which at the time were focused on identifying small molecules that could inhibit fungal invasins, along with Mark Currie who had also worked at Searle division of Monsanto with Talley, and then had gone to Sepracor, and also Richard Bailey, who had run Monsanto's nutritional business. Currie directed the efforts that led to the discovery of linaclotide, which was based on an enterotoxin produced by some strains of Escherichia coli that cause traveler’s diarrhea.

Aptalis Pharma US, Inc. markets pharmaceutical products and services for the treatment of gastrointestinal diseases and disorders. It offers pancrelipase capsules, ursodiol tablets, porfimer sodium for injections, shake mixes, calorie boosters, clearance devices and multivitamin supplements. The firm also provides products for active ulcerative, liver diseases, pancreatic diseases, cystic fibrosis, chronic obstructive pulmonary disease, HIV/AIDS and cancer. The company was founded in 1991 and is headquartered in Wilmington, DE.

Pharmbio Korea Company Ltd is a pharmaceutical company. The Company develops drugs for urinary tract infections, diuresis & relaxes urinary tract spasm, gallstones, and difficult digestion.

Norgine Europe BV provides pharmaceutical products. It offers products for acute and chronic illnesses, including gastroenterology, hepatology, incontinence and pain management. The company was founded in 1906 and is headquartered in Amsterdam, the Netherlands.

Taejoon Pharm Co. Ltd. is a South Korean private company. The firm manufactures and sells ophthalmic agents and gastrointestinal products.

Motus G.I. Medical Technologies Ltd. develops a system for diagnosis and treatment of large intestine diseases. The company was founded by Boris Shtul on October 6, 2008 and is headquartered in Tirat Carmel, Israel.

CTC Bio, Inc. engages in the manufacture of pharmaceuticals, functional food and animal health products. It operates through the following divisions: Animal Health and Human Medicine. The Animal Health division produces antibiotic, enzyme, probiotic products and bird flu-related diagnostic kits and disinfectants. The Human Medicine division manufactures and supplies pharmaceuticals, pharmaceutical raw materials and functional health products. The company was founded on December 28, 1995 and is headquartered in Hwaseong-si, South Korea.

Hengyi Biomedicine (Shanghai) Co., Ltd. is a Chinese company located in Shanghai. The firm engages in conducting biotechnological research and developmental services. It was founded by Heng Li.

Kingston General Hospital operates as a teaching hospital, which provides complex-acute and specialty care services, conducts research, and trains healthcare professionals. It offers cancer, cardiac, critical, diagnostic imaging, emergency, medicine, mental health, obstetrical, pediatric, pharmacy, and surgical care services, laboratory services, and other regional healthcare programs. The company was founded in 1831 and is headquartered in Ontario, Canada.

InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden.

Aptalis Pharma Canada ULC provided pharmaceutical products. The company was founded in 1982 and was headquartered in Mount Saint-Hilaire, Canada.

Nogra Pharma Ltd. operates as a pharmaceutical company. It offers brand which include Lialda and Mezavant. The firm focuses on the treatment of ulcerative colitis and crohn's disease. The company was founded in 2005 and is headquartered in Dublin, Ireland.

JetPrep Ltd. engages in the development, manufacture, and marketing of medical devices. It offers the JetPrep Flushing Device that assists clinicians in endoscopy procedures. The company was founded in 2007 and is headquartered in Herzliya, Israel.

Shenzhen Very Road Industrial Development Co., Ltd., established on 2001-07-23, Business scope includes general business items:Invest in business(Specific projects will be reported separately),in the advertising business,Exhibition planning,meeting planning,Image Design,Enterprise Organization Planning,building materials,steel bar,decorative material,hardware equipment,auto parts,car services,Sales of fire fighting equipment;Sales of flowers and trees,Landscape Design,construction machinery rental,Domestic Trade,primary agricultural products,fruit,electronics sales,Computer software technology service,tea utensils,tea set,Purchase and sale of craft gifts;Domestic Trade,Engaged in the import and export of goods and technology.(law,Administrative regulations,Except for items that are subject to approval prior to registration by decision of the State Council).,The licensing program is:Class II:6826Physiotherapy and Rehabilitation Equipment,6854operating room,emergency room,Manufacture of medical room equipment and appliances;Three categories:Sales of physical therapy and rehabilitation equipment.

Sanovel Ila�� Sanayi ve Ticaret AS engages in the manufacture of pharmaceutical products. It develops medicaments, such as antihistamines, expectorants, decongestants, antibiotics, and anti-inflammatory drugs, as well as offers research and development services. The company was founded by Erol Toks��z in 1983 and is headquartered in Istanbul, Turkey.

Apharm SRL manufactures pharmaceutical products. The firm engages in the provision of nutraceutical and medical device development. The company was founded by Angelo Pizzoni and Paolo Pizzoni in 2003 and is headquartered in Arona, Italy.

Aptalis Pharma (known as Axcan Pharma until May 2011) is a privately-held, leading specialty pharmaceutical company that develops and markets a wide range of products to treat gastrointestinal diseases and disorders, such as inflammatory bowel disease, cholestatic liver diseases, irritable bowel syndrome, and complications related to pancreatic insufficiency. Aptalis hopes to improve the quality of care and health of patients suffering from gastrointestinal diseases and disorders by providing effective therapies for patients and their specialized caregivers. Aptalis was acquired by [TPG Capital](/organization/tpg-capital) in 2008, and it acquired [Eurand](/organization/eurand) in 2010. It [changed its name](http://www.thepressreleasewire.com/client/aptalispharma/release.jsp?actionFor=1437343&releaseSeq=0&year=2011) from Axcan Pharma to Aptalis in May 2011.